Luteinizing Hormone-Releasing Hormone (LHRH) Conjugated Magnetite Nanoparticles as MRI Contrast Agents for Breast Cancer Imaging

Luteinizing Hormone-Releasing Hormone (LHRH) Conjugated Magnetite Nanoparticles as MRI Contrast Agents for Breast Cancer Imaging

Targeted magnetic resonance imaging (MRI) contrast agents offer platforms for the specific detection of many diseases, including cancer. This study explores the applicability of luteinizing hormone-releasing hormone-conjugated PEG-coated magnetite nanoparticles (LHRH-MNPs) to the enhancement of trip...

Full description

Bibliographic Details
Main Authors: Jingjie Hu, John Obayemi, Karen Malatesta, Edward Yurkow, Derek Adler, Winston Soboyejo
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Applied Sciences
Subjects:
triple negative breast cancer (TNBC)
luteinizing hormone-releasing hormone (LHRH)
magnetite nanoparticles
magnetic resonance imaging (MRI)
cancer detection
Online Access:https://www.mdpi.com/2076-3417/10/15/5175

Internet

https://www.mdpi.com/2076-3417/10/15/5175

Similar Items